Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.36% | 24.66% | 21.42% | 26.98% | 41.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.36% | 24.66% | 21.42% | 26.98% | 41.77% |
| Cost of Revenue | 3.66% | -8.95% | -16.53% | -0.84% | 23.45% |
| Gross Profit | 37.45% | 29.89% | 28.09% | 31.64% | 44.72% |
| SG&A Expenses | 30.37% | 25.27% | 20.73% | 21.21% | 23.67% |
| Depreciation & Amortization | 20.17% | 29.90% | 33.99% | 35.78% | 55.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.40% | 19.53% | 14.24% | 17.22% | 25.51% |
| Operating Income | 23.13% | 19.10% | 29.26% | 30.57% | 36.37% |
| Income Before Tax | -123.25% | -1.59% | 36.20% | 58.14% | 68.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -123.25% | -1.59% | 23.81% | 18.36% | 45.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 80.98% | -33.99% | -37.47% | -19.76% | -11.69% |
| Net Income | -124.59% | -2.33% | 23.50% | 18.32% | 45.79% |
| EBIT | 23.13% | 19.10% | 29.26% | 30.57% | 36.37% |
| EBITDA | 63.02% | 52.95% | 59.89% | 55.05% | 58.76% |
| EPS Basic | -118.26% | 1.25% | 26.08% | 19.84% | 47.81% |
| Normalized Basic EPS | -7.11% | -2.68% | 17.05% | 26.80% | 38.06% |
| EPS Diluted | -118.26% | 1.25% | 26.08% | 20.80% | 48.27% |
| Normalized Diluted EPS | -7.11% | -2.68% | 17.05% | 25.73% | 37.28% |
| Average Basic Shares Outstanding | 2.48% | 2.86% | 3.00% | 3.64% | 4.72% |
| Average Diluted Shares Outstanding | 2.48% | 2.86% | 3.00% | 2.46% | 3.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |